Immucor News

October 1, 2008 Conference calls scheduled at 12 to 5 p.m. on Investrend Broadcast via partner BestCalls include Atmos Energy Corporation , Patterson-UTI Energy Inc.

Immucor, Inc. continues to progress in the development of another version of the Galileo.

Zacks Earnings and Margins Strategy highlights: Immucor, Central European Distribution, Greif and KapStone Paper and Packaging.

Blood reagent systems maker Immucor Inc. reported Wednesday its profit increased 19 percent in fiscal 2008.

Every day, the sun rises on Wall Street, and a plethora of professional analysts wake to issue new opinions on stocks.

"Growth and value investing are joined at the hip." You think that's crazy? Tell Warren Buffett.

Editor's note: The AJC will follow the highs and lows of this major kitchen remodel in a Druid Hills home from start to finish.

Click to exclude managers not in the List of Gurus. *The price and date might not be the actual time and price at which the transactions were made.

Norcross - Wednesday, June 04, 2008 Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance Immucor, Inc.

Q: Your Web site says Immucor revolutionized the blood bank industry. How did you do this? A: We believe we have revolutionized the blood bank industry by bringing automation into blood banks.

The companies that rose to the top of this year's Georgia 100 Best of Business report represented the usual mix of big and small , but the Top 10 includes an uncommon number of repeat performers.

Immucor, Inc. Company Profile - View Immucor, Inc. Company Information Use of, or registration on, this site constitutes acceptance of our User Agreement and Privacy Policy . via Atlanta Business Chronicle

Immucor Inc. replied on Tuesday to a warning letter from the Food and Drug Administration that pointed out problems of manufacturing practices in the company. via International Business Times

Milan, April 17 - Former health minister Girolamo Sirchia, the man behind Italy's smoking ban, was convicted Thursday of accepting kickbacks in a trial into graft at a well-known Milan hospital. via ANSA.it

Welcome back to another Foolish review of the hottest stocks as ranked by Motley Fool CAPS . via The Motley Fool

Author: 123jump.com Staff 123jump.com Last Update: 10:23 PM EDT April 07 2008 RiskMetrics Group, corporate governance consultant, reported fourth quarter revenue rise of 29% and net income decline of 66%. ... via Ticker

“We think the company is on track to reach its target of 250 Echo instrument orders in the first 12 months post-clearance, which ends in June 2008”

Immucor rallied on Wednesday after falling off earlier in the month. The company may be increasing prices to combat dilution from its acquisition of BioArray Solutions, but analysts say, "Stay tuned." The ... via Forbes.com

Products are primarily used to type blood and detect foreign antibodies. Immucor sells its systems and reagent tests directly in North America, Western Europe and Japan. via Blogging Stocks

Price increases, favorable exchange rates and sales gains sent Immucor 's profit soaring 29% in the third quarter. via Forbes.com

Immucor Inc. shares pulled higher Tuesday evening after the company backed its yearly financial forecast and posted higher quarterly revenue than expected by analysts. via MarketWatch